We offer you an overview of useful health news.
TEL AVIV - Israel’s Pluristem Therapeutics Inc reported on Wednesday positive results from a series of studies in animals of its placenta-based stem cell therapy to treat acute radiation syndrome (ARS).
Magenta Medical, an Israeli developer of a miniaturized blood pump to help treat heart failure, has raised funds from investors led by venture capital firm New Enterprise Associates (NEA), a US-based VC firm.
The future of cancer treatments rests also on the shoulders of Natural Killer cells, according to a recent study conducted by Israeli Professor Angel Porgador, of the Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, and the National Institute of Biotechnology in the Negev (NIBN).
Math model developed by Hebrew University team could pave the way for physicians to see beginnings of Alzheimer’s or Parkinson’s.
Weizmann Institute team says early interactions between immune cells and bacteria determine the outcome of illnesses.
Tel Aviv University (TAU) researchers say they have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer.
Israel’s Nurami Medical is testing its nanofiber bandage that mimics the brain’s protective membrane and guards against infection and leakage.
The researchers turned their attention to diagnosing the onset of tuberculosis, caused by bacteria that can hide dormant in the body for years.
Innovative AI system manages to identify all important clinical cases of medium or severe obstructive sleep apnea.
